This accountability reassures clients that outcomes will be safe
Additionally, it should not be used if a patient has an ongoing gallbladder inflammation, severe pain or burning sensation in the stomach area, difficulty breathing, poor gastrointestinal tolerability to semaglutide (the main active ingredient of Wegovy), severe nausea, and other symptoms occurring in response to GLP 1 receptor agonists
F., Kochhar, P., Jasper, S., Brotherton, B., Orban, B., & Lulic, Z
The Breakthrough in Weight Loss Medicine How It Works Smart Science for Real Results Why Clients Love Our Program Designed Around You Not a One-Size-Fits-All Plan Our Expertise Sets Us Apart Led by Physicians
The starting dose varies by formulation, with R1 beginning at 3 mg and R2 at 1.5 mg daily for 30 days, allowing the body to adjust while minimizing gastrointestinal side effects